Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
Picket, AndyToxin Science Limited, Wrexham, UK; Botulinum research Center, UMASS Dartmouth, MA, USAModern clinical use of botulinum toxin (BoNT) by doctors requires evidence- based facts and data to support their work. In particular, these need to be unbiased and complete. Too often in the past, spe...
Enregistré dans:
Auteur principal: | |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4f46c94a934842248ae15ea23865ba92 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|